[1] 祝永明, 涂厉标, 杨毅, 等. RP-HPLC 测定血浆中罗哌卡因的浓度[J]. 中国医院药学杂志, 2008, 28(5): 75-76. [2] 徐红蓉, 许剑安, 陈伟力, 等. 罗哌卡因在手术病人的药代动力学[J]. 中国临床药理学杂志, 2003, 19(6): 440-442. [3] 王珊娟, 张马忠, 周颖, 等. 下腹部手术病人硬膜外注射甲磺酸罗哌卡因的药代动力学[J]. 中华麻醉学杂志, 2006, 26(9): 810-812. [4] Pere P, Salonen M, Jokinen M, et al. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block[J]. Anesth Analg, 2003, 96 (2): 563-569. [5] 解大建, 吴新民, 许幸, 等. 硬膜外阻滞时罗哌卡因和布比卡因的药代动力学[J]. 中华麻醉学杂志, 1999, 19(8): 459-460. [6] 舒化青, 张小洺, 姚尚龙, 等. 不同浓度罗哌卡因用于腰丛-坐骨神经阻滞的药代动力学[J]. 中华麻醉学杂志, 2006, 26(11): 1018-1020. [7] Lee A, Fagan D, Lamont M, et al. Disposition kinetics of ropivacaine in humans[J]. Anesth Analg, 1989, 66(6): 736-738. [8] Simon MJ, Veering BT, Vletter AA, et al. The effect of age on the systemic absorption and systemic disposition of ropivacaine after epidural administration [J]. Anesth Analg, 2006, 102(1): 276-282. [9] 易三平, 姚尚龙, 孟庆新, 等. 罗哌卡因在硬膜外阻滞时的药代动力学研究[J]. 中华麻醉学杂志, 2001, 21(8): 500-501. [10] Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine [J]. Anesth Analg, 1989, 69(5): 563-569. |